METHOCINNAMOX (MCAM): A NOVEL μ OPIOID RECEPTOR ANTAGONIST FOR TREATING OPIOID USE DISORDER AND OPIOID OVERDOSE

被引：0
|
作者：
France, C. P. [1 ,2 ,3 ]
Gerak, L. R. [1 ,2 ,3 ]
Maguire, D. R. [1 ,2 ,3 ]
Javors, M. A.
Woods, J. H. [1 ,2 ,3 ]
Husbands, S. M. [4 ]
Disney, A. [4 ]
机构：
[1] UT Hlth San Antonio, Dept Pharmacol, San Antonio, TX USA
[2] UT Hlth San Antonio, Dept Psychiat, San Antonio, TX USA
[3] UT Hlth San Antonio, Addict Res Treatment & Training Ctr Excellence, San Antonio, TX USA
[4] Univ Bath, Dept Pharm & Pharmacol, Bath, Avon, England
来源：
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | 2019年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
006
引用
收藏
页码：354A / 354A
页数：1
相关论文
共 50 条
  • [21] Methocinnamox (MCAM) is an Effective Long-Term Antagonist of Peripheral Mu, but not Kappa or Delta Opioid Receptors In Vivo
    Jennings, Elaine M.
    Disney, Alex
    Husbands, Stephen
    Winger, Gail
    Berg, Kelly A.
    Clarke, William P.
    Woods, James H.
    [J]. FASEB JOURNAL, 2019, 33
  • [22] The Potential of Methocinnamox as a Future Treatment for Opioid Use Disorder: A Narrative Review
    Jordan, Colleen G.
    Kennalley, Amy L.
    Roberts, Alivia L.
    Nemes, Kaitlyn M.
    Dolma, Tenzing
    Piper, Brian J.
    [J]. PHARMACY, 2022, 10 (03)
  • [23] Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: A cohort study
    Macmadu, Alexandria
    Paull, Kimberly
    Youssef, Rouba
    Batthala, Sivakumar
    Wilson, Kevin H.
    Samuels, Elizabeth A.
    Yedinak, Jesse L.
    Marshall, Brandon D. L.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2021, 226
  • [24] Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: A cohort study
    Macmadu, Alexandria
    Paull, Kimberly
    Youssef, Rouba
    Batthala, Sivakumar
    Wilson, Kevin H.
    Samuels, Elizabeth A.
    Yedinak, Jesse L.
    Marshall, Brandon D. L.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2021, 219
  • [25] The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017
    Florence, Curtis
    Luo, Feijun
    Rice, Ketra
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2021, 218
  • [26] Semaglutide and Opioid Overdose Risk in Patients With Type 2 Diabetes and Opioid Use Disorder
    Wang, William
    Volkow, Nora D.
    Wang, QuangQiu
    Berger, Nathan A.
    Davis, Pamela B.
    Kaelber, David C.
    Xu, Rong
    [J]. JAMA NETWORK OPEN, 2024, 7 (09)
  • [27] Opioid-overdose laws association with opioid use and overdose mortality
    McClellan, Chandler
    Lambdin, Barrot H.
    Ali, Mir M.
    Mutter, Ryan
    Davis, Corey S.
    Wheeler, Eliza
    Pemberton, Michael
    Kral, Alex H.
    [J]. ADDICTIVE BEHAVIORS, 2018, 86 : 90 - 95
  • [28] Opioid Use and Opioid Use Disorder in Pregnancy
    Mascola, Maria A.
    Borders, Ann E.
    Terplan, Mishka
    [J]. OBSTETRICS AND GYNECOLOGY, 2017, 130 (02): : E81 - E94
  • [29] Antagonist Treatment for Opioid Use Disorder Reply
    Wakeman, Sarah E.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2017, 130 (03): : E119 - E119
  • [30] The Importance of Treating Opioid Use Disorder in Pregnancy
    Grady, Deborah
    [J]. JAMA INTERNAL MEDICINE, 2024, 184 (03) : 255 - 255
12345